Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-17-005517
Filing Date
2017-07-19
Accepted
2017-07-19 17:25:08
Documents
2
Period of Report
2017-07-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT p7571874.html 3  
1 OWNERSHIP DOCUMENT p7571874.xml 3 6495
2 d7571874_poa.txt EX-99 4865
  Complete submission text file 0000919574-17-005517.txt   13903
Mailing Address C/O CAXTON ASSOCIATES 500 PARK AVENUE NEW YORK NY 10022
Business Address
Kovner Bruce (Reporting) CIK: 0001325713 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38150 | Film No.: 17972906

Mailing Address 731 ALEXANDER ROAD BUILDING 2 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Reporting) CIK: 0001388551 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38150 | Film No.: 17972907

Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAXTON CORPORATION 731 ALEXANDER ROAD, BUILDING #2 PRINCETON NJ 08540
Business Address C/O CAXTON CORPORATION 731 ALEXANDER ROAD, BUILDING #2 PRINCETON NJ 08540 609-419-1800
CDK ASSOCIATES, L.L.C. (Reporting) CIK: 0001576081 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38150 | Film No.: 17972908